Article Text

PDF

Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.
  1. S A Johnson,
  2. P A Spiller,
  3. C M Faull
  1. St Mary's Hospice, Selly Park, Birmingham, UK.

Abstract

Pain in hypertrophic pulmonary osteoarthropathy (HPOA) due to periostitis and arthropathy can be a particularly disabling symptom, and resistant to a wide variety of treatments. The effectiveness of subcutaneous octreotide in relieving this pain in a patient with HPOA is reported.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.